• Home
  • Tutorial
  • Analysis


Select cancer

    Bladder urothelial carcinoma▼
    Neuronal Basal-squamous Luminal Luminal-Infiltrated Luminal-Papillary
    Breast invasive carcinoma ▼
    TNBC HER2+ve Luminal
    Colon adenocarcinoma ▼
    Adenocarcinoma Mucinous adenocarcinoma
    Esophageal carcinoma ▼
    Adenocarcinoma Squamous cell carcinoma
    Prostate adenocarcinoma ▼
    ETS-Fusion No ETS-fusion ERG-fusion
    Uterine Corpus Endometrial Carcinoma ▼
    Endometrioid Serous Mixed
    Thyroid carcinoma ▼
    Classical type Follicular cell Tall cell
    Stomach adenocarcinoma ▼
    Adenocarcinoma NOS Adenocarcinoma Diffuse Adenocarcinoma Signet Ring Intestinal Adenocarcinoma NOS Intestinal Adenocarcinoma Tubular Intestinal Adenocarcinoma Mucinous Intestinal Adenocarcinoma Papillary
    Rectum adenocarcinoma ▼
    Adenocarcinoma Mucinous adenocarcinoma
    Lung adenocarcinoma ▼
    LUAD Not Otherwise Specified LUAD Mixed Subtype Brochioloalveolar Carcinoma Non mucinous Lung Acinar Adenocarcinoma Mucinous (Colloid) Carcinoma Lung Papillary Adenocarcinoma
    Lung squamous cell carcinoma ▼
    LUSC Not Otherwise Specified Lung Basaloid Squamous Cell Carcinoma
    Kidney renal clear cell carcinoma ▼
    ccA subtype ccB subtype
    Kidney renal papillary cell carcinoma ▼
    Type1 papillary subtype Type2 papillary subtype CIMP Unclassified papillary subtype
    Head and Neck squamous cell carcinoma
    Liver hepatocellular carcinoma
    Kidney chromophobe

 Previous 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 Next 





 Previous 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 Next 



© bcrf

Home | Tutorial | Analysis | About Us | Contact Us | Citations | Donate | Twitter
Please cite: Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Rodriguez IP, Chakravarthi BVSK and Varambally S. UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia (New York, N.Y.) 19(8):649-658. August 2017